90 results
Page 4 of 5
8-K
EX-4.3
snu5wc6 vyjuxlj8
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.3
91s36uq7
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.2
ackq p82f6
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.1
wiu23l z4c2
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.1
tjb3 yj2rxw
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.2
itlu6jzk
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.1
zo5 cy7z3g78
5 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
roil hbd5i
14 Jan 10
MDRNA, Inc. Raises $5.5 Million in Registered Direct Offering
12:00am
8-K
EX-4.1
stbfcpep44g
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.2
uh3id8rus m3
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.1
cbh 1ypvzq4szu4ww
19 Jan 07
Entry into a Material Definitive Agreement
12:00am
S-8
EX-4.5
d7qlosxkb
10 Jul 02
Registration of securities for employees
12:00am
8-K
EX-4.1
romuckn7ir29r8aec
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am
8-K
EX-4.2
5fr4if9r iwfad1ce4
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am